$1.72 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 203 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIOGEN INCcall | $71,155,000 | -3.2% | 348,900 | 0.0% | 4.13% | +73.4% | ||
| SAREPTA THERAPEUTICS INCcall | $14,992,000 | -4.0% | 200,000 | 0.0% | 0.87% | +71.8% | ||
| CYTOKINETICS INCnote 4.000%11/1 | $9,702,000 | +6.0% | 25,000 | 0.0% | 0.56% | +89.6% | ||
| APELLIS PHARMACEUTICALS INCcall | $9,044,000 | -11.0% | 200,000 | 0.0% | 0.52% | +59.1% | ||
| OLINK HLDG ABcall | $8,968,000 | -13.9% | 590,000 | 0.0% | 0.52% | +54.1% | ||
| ALNYLAM PHARMACEUTICALS INCput | $7,293,000 | -10.7% | 50,000 | 0.0% | 0.42% | +60.0% | ||
| INTEGRA LIFESCIENCES HLDGS Cput | $6,694,000 | -15.9% | 123,900 | 0.0% | 0.39% | +50.8% | ||
| MASS | 908 DEVICES INC | $6,101,000 | +8.3% | 296,288 | 0.0% | 0.35% | +93.4% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $6,073,000 | -4.2% | 987,411 | 0.0% | 0.35% | +71.4% | |
| EXACT SCIENCES CORPcall | $5,318,000 | -43.7% | 135,000 | 0.0% | 0.31% | +1.0% | ||
| SCHRODINGER INCcall | $4,886,000 | -22.6% | 185,000 | 0.0% | 0.28% | +38.5% | ||
| EXACT SCIENCES CORPput | $3,939,000 | -43.7% | 100,000 | 0.0% | 0.23% | +0.9% | ||
| ACADIA PHARMACEUTICALS INCcall | $2,818,000 | -41.8% | 200,000 | 0.0% | 0.16% | +4.5% | ||
| ICAD | ICAD INC | $2,692,000 | -10.3% | 672,989 | 0.0% | 0.16% | +60.8% | |
| NYXOAH S A | $2,185,000 | -49.2% | 221,949 | 0.0% | 0.13% | -9.3% | ||
| AVITA MEDICAL INCcall | $2,138,000 | -44.0% | 450,000 | 0.0% | 0.12% | 0.0% | ||
| TKNO | ALPHA TEKNOVA INC | $2,109,000 | -39.2% | 251,112 | 0.0% | 0.12% | +8.9% | |
| GHRS | GH RESEARCH PLCordinary shares | $2,081,000 | -45.4% | 208,527 | 0.0% | 0.12% | -2.4% | |
| ANAVEX LIFE SCIENCES CORPcall | $2,002,000 | -18.7% | 200,000 | 0.0% | 0.12% | +45.0% | ||
| SONENDO INC | $1,760,000 | -57.1% | 1,023,424 | 0.0% | 0.10% | -23.3% | ||
| APEN | APOLLO ENDOSURGERY INC | $1,559,000 | -39.7% | 427,057 | 0.0% | 0.09% | +8.3% | |
| FLDM | STANDARD BIOTOOLS INC | $1,360,000 | -55.4% | 850,000 | 0.0% | 0.08% | -20.2% | |
| SDGR | SCHRODINGER INC | $1,321,000 | -22.6% | 50,000 | 0.0% | 0.08% | +40.0% | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $1,220,000 | -37.4% | 105,460 | 0.0% | 0.07% | +12.7% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $1,214,000 | -41.7% | 150,000 | 0.0% | 0.07% | +4.4% | |
| MDVL | MEDAVAIL HOLDINGS INC | $1,093,000 | +57.7% | 714,120 | 0.0% | 0.06% | +186.4% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $1,036,000 | +0.5% | 104,026 | 0.0% | 0.06% | +81.8% | |
| PHAT | PHATHOM PHARMACEUTICALS INC | $864,000 | -38.0% | 102,328 | 0.0% | 0.05% | +11.1% | |
| TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $502,000 | -5.6% | 5,000 | 0.0% | 0.03% | +70.6% | ||
| CORTEXYME INCcall | $444,000 | -64.1% | 200,000 | 0.0% | 0.03% | -35.0% | ||
| UNITY BIOTECHNOLOGY INCcall | $442,000 | -49.7% | 783,800 | 0.0% | 0.03% | -7.1% | ||
| GOSSAMER BIO INCnote 5.000% 6/0 | $374,000 | -7.0% | 5,000 | 0.0% | 0.02% | +69.2% | ||
| IVERIC BIO INCput | $327,000 | -42.8% | 34,000 | 0.0% | 0.02% | 0.0% | ||
| SOMALOGIC INC*w exp 08/31/202 | $155,000 | -62.5% | 204,401 | 0.0% | 0.01% | -30.8% | ||
| TALKW | TALKSPACE INC*w exp 06/21/202 | $149,000 | +44.7% | 427,194 | 0.0% | 0.01% | +200.0% | |
| VINC | VINCERX PHARMA INC | $143,000 | -67.1% | 108,459 | 0.0% | 0.01% | -42.9% | |
| SVRA | SAVARA INC | $144,000 | +16.1% | 95,014 | 0.0% | 0.01% | +100.0% | |
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $120,000 | -31.8% | 199,648 | 0.0% | 0.01% | +16.7% | ||
| MTCR | METACRINE INC | $99,000 | -18.2% | 198,230 | 0.0% | 0.01% | +50.0% | |
| MAPSW | WM TECHNOLOGY INC*w exp 06/16/202 | $33,000 | -70.0% | 50,000 | 0.0% | 0.00% | -50.0% | |
| RENOVACOR INC*w exp 99/99/999 | $8,000 | -80.5% | 150,632 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.